251 related articles for article (PubMed ID: 24184562)
1. Epoxide group relationship with cytotoxicity in withanolide derivatives from Withania somnifera.
Joshi P; Misra L; Siddique AA; Srivastava M; Kumar S; Darokar MP
Steroids; 2014 Jan; 79():19-27. PubMed ID: 24184562
[TBL] [Abstract][Full Text] [Related]
2. Differential activities of the two closely related withanolides, Withaferin A and Withanone: bioinformatics and experimental evidences.
Vaishnavi K; Saxena N; Shah N; Singh R; Manjunath K; Uthayakumar M; Kanaujia SP; Kaul SC; Sekar K; Wadhwa R
PLoS One; 2012; 7(9):e44419. PubMed ID: 22973447
[TBL] [Abstract][Full Text] [Related]
3. A critical assessment of the whole plant-based phytotherapeutics from
Kumar P; Banik SP; Goel A; Chakraborty S; Bagchi M; Bagchi D
Toxicol Mech Methods; 2023 Oct; 33(8):698-706. PubMed ID: 37533233
[No Abstract] [Full Text] [Related]
4. 5,6-de-epoxy-5-en-7-one-17-hydroxy withaferin A, a new cytotoxic steroid from Withania somnifera L. Dunal leaves.
Siddique AA; Joshi P; Misra L; Sangwan NS; Darokar MP
Nat Prod Res; 2014; 28(6):392-8. PubMed ID: 24422976
[TBL] [Abstract][Full Text] [Related]
5. Withaferin A-related steroids from Withania aristata exhibit potent antiproliferative activity by inducing apoptosis in human tumor cells.
Llanos GG; Araujo LM; Jiménez IA; Moujir LM; Bazzocchi IL
Eur J Med Chem; 2012 Aug; 54():499-511. PubMed ID: 22705001
[TBL] [Abstract][Full Text] [Related]
6. Organic cultivation of Ashwagandha with improved biomass and high content of active Withanolides: Use of Vermicompost.
Kaur A; Singh B; Ohri P; Wang J; Wadhwa R; Kaul SC; Pati PK; Kaur A
PLoS One; 2018; 13(4):e0194314. PubMed ID: 29659590
[TBL] [Abstract][Full Text] [Related]
7. Chlorinated and diepoxy withanolides from Withania somnifera and their cytotoxic effects against human lung cancer cell line.
Choudhary MI; Hussain S; Yousuf S; Dar A; Mudassar ; Atta-ur-Rahman
Phytochemistry; 2010 Dec; 71(17-18):2205-9. PubMed ID: 21044792
[TBL] [Abstract][Full Text] [Related]
8. Metabolic characterization of Withania somnifera from different regions of India using NMR spectroscopy.
Namdeo AG; Sharma A; Yadav KN; Gawande R; Mahadik KR; Lopez-Gresa MP; Kim HK; Choi YH; Verpoorte R
Planta Med; 2011 Nov; 77(17):1958-64. PubMed ID: 21728148
[TBL] [Abstract][Full Text] [Related]
9. Withanolides from Withania aristata and their cytotoxic activity.
Llanos GG; Araujo LM; Jiménez IA; Moujir LM; Vázquez JT; Bazzocchi IL
Steroids; 2010 Dec; 75(12):974-81. PubMed ID: 20542049
[TBL] [Abstract][Full Text] [Related]
10. Hypoglycemic activity of withanolides and elicitated Withania somnifera.
Gorelick J; Rosenberg R; Smotrich A; Hanuš L; Bernstein N
Phytochemistry; 2015 Aug; 116():283-289. PubMed ID: 25796090
[TBL] [Abstract][Full Text] [Related]
11. Withanolides against TLR4-Activated Innate Inflammatory Signalling Pathways: A Comparative Computational and Experimental Study.
Purushotham PM; Kim JM; Jo EK; Senthil K
Phytother Res; 2017 Jan; 31(1):152-163. PubMed ID: 27859734
[TBL] [Abstract][Full Text] [Related]
12. Subcritical water extraction of withanosides and withanolides from ashwagandha (Withania somnifera L) and their biological activities.
Nile SH; Nile A; Gansukh E; Baskar V; Kai G
Food Chem Toxicol; 2019 Oct; 132():110659. PubMed ID: 31276745
[TBL] [Abstract][Full Text] [Related]
13. Analysis of withanolides in root and leaf of Withania somnifera by HPLC with photodiode array and evaporative light scattering detection.
Chaurasiya ND; Uniyal GC; Lal P; Misra L; Sangwan NS; Tuli R; Sangwan RS
Phytochem Anal; 2008; 19(2):148-54. PubMed ID: 17879227
[TBL] [Abstract][Full Text] [Related]
14. Leaf spot disease adversely affects human health-promoting constituents and withanolide biosynthesis in Withania somnifera (L.) Dunal.
Singh V; Singh B; Sharma A; Kaur K; Gupta AP; Salar RK; Hallan V; Pati PK
J Appl Microbiol; 2017 Jan; 122(1):153-165. PubMed ID: 27709727
[TBL] [Abstract][Full Text] [Related]
15. Steroidal lactones from Withania somnifera, an ancient plant for novel medicine.
Mirjalili MH; Moyano E; Bonfill M; Cusido RM; Palazón J
Molecules; 2009 Jul; 14(7):2373-93. PubMed ID: 19633611
[TBL] [Abstract][Full Text] [Related]
16. Extraction Optimization for Phenolic- and Withanolide-Rich Fractions from
Kumar S; Singh R; Gajbhiye N; Dhanani T
J AOAC Int; 2018 Nov; 101(6):1773-1780. PubMed ID: 29945694
[No Abstract] [Full Text] [Related]
17. Metabolomic and biotechnological approaches to determine therapeutic potential of Withania somnifera (L.) Dunal: A review.
Tripathi N; Shrivastava D; Ahmad Mir B; Kumar S; Govil S; Vahedi M; Bisen PS
Phytomedicine; 2018 Nov; 50():127-136. PubMed ID: 30466971
[TBL] [Abstract][Full Text] [Related]
18. Withanolide Z, a new chlorinated withanolide from Withania somnifera.
Pramanick S; Roy A; Ghosh S; Majumder HK; Mukhopadhyay S
Planta Med; 2008 Nov; 74(14):1745-8. PubMed ID: 18988152
[TBL] [Abstract][Full Text] [Related]
19. Standardized root extract of Withania somnifera and Withanolide A exert moderate vasorelaxant effect in the rat aortic rings by enhancing nitric oxide generation.
Pathak P; Shukla P; Kanshana JS; Jagavelu K; Sangwan NS; Dwivedi AK; Dikshit M
J Ethnopharmacol; 2021 Oct; 278():114296. PubMed ID: 34090907
[TBL] [Abstract][Full Text] [Related]
20. Withanolides from
Khanal P; Chikhale R; Dey YN; Pasha I; Chand S; Gurav N; Ayyanar M; Patil BM; Gurav S
J Biomol Struct Dyn; 2022 Aug; 40(12):5295-5308. PubMed ID: 33459174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
